| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 02/15/2006 | CN1241901C Perfluoronated cycle-containing tertiary amines used as basis for gas-conveying emulsions and preparation method |
| 02/15/2006 | CN1241651C Hemostatic antibiotic products and preparing method thereof |
| 02/15/2006 | CN1241618C Application of Ypsilandra herbs for preparing medicines for treating hemorrhagic diseases |
| 02/15/2006 | CN1241572C Slow and control release aspirin capsule formulation and method for making same |
| 02/15/2006 | CN1241570C Bile secretion promoting composition |
| 02/15/2006 | CN1241548C Stable protein: phospholipid composition and method |
| 02/14/2006 | US6998503 crystallized as an anhydrous, stoichiometric 1.5 HCl salt; inhibiting or modulating nitric oxide synthesis |
| 02/14/2006 | US6998469 for treating thrombosis and other vascular diseases |
| 02/14/2006 | US6998468 Anti-C2/C2a inhibitors of complement activation |
| 02/14/2006 | US6998409 Drugs for treating chronic pain; stereoisomers; chemical synthesis from intermediates; nontoxic |
| 02/14/2006 | US6998408 6-5, 6-6, or 6-7 Heterobicycles as factor Xa inhibitors |
| 02/14/2006 | US6998263 Methods of preparing and using a viral vector library |
| 02/14/2006 | CA2450740C Beta-amino tetrahydroimidazo (1, 2-a) pyrazines and tetrahydrotrioazolo (4, 3-a) pyrazines as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 02/14/2006 | CA2378533C Erythropoietin conjugates with polyethylenglycol |
| 02/14/2006 | CA2375385C Propargyl phenyl ether a2a receptor agonists |
| 02/14/2006 | CA1341497C Biologically active fragments of human antihemophilic factor and method for preparation thereof |
| 02/14/2006 | CA1341496C Production of thrombin inhibitors |
| 02/09/2006 | WO2006014005A1 Pyrazole derivative |
| 02/09/2006 | WO2005111083A3 Antibodies specific for glycoprotein vi and methods of producing these antibodies |
| 02/09/2006 | WO2002088316A3 G-protein coupled receptors |
| 02/09/2006 | US20060031956 Nucleotide sequences for gene regulation and methods of use thereof |
| 02/09/2006 | US20060030572 Method of improved diuresis in individuals with impaired renal function |
| 02/09/2006 | US20060030568 Crystal modificaion of a N-phenyl-2-pyrimidineamine derivative, processed for its manufacture and its use |
| 02/09/2006 | US20060030561 2-Benzyl-2-hydroxy-4-methyl-4-phenylpentanoic acid (1-oxo-1,3-dihydroisobenzofuran-5-yl)amide for example; treating type II diabetes, obesity, hypertension, arteriosclerosis, or glaucoma |
| 02/09/2006 | US20060030540 Transgenic animals produced using oral administration of a genetic agent coupled to a transporting agent |
| 02/09/2006 | US20060029592 Methods of treating peripheral arterial occlusions |
| 02/09/2006 | US20060029581 Human growth hormone to stimulate mobilization of pluripotent hematopoietic stem cells |
| 02/09/2006 | CA2578261A1 Pyrazole derivative |
| 02/09/2006 | CA2574626A1 Antiplatelet agent and process for producing the same |
| 02/08/2006 | EP1623984A1 Polymorphic form I of 5-[4-[[3-methyl-4-oxo-3,4-dihydroquinazolin-2yl]methoxy]benzyl]thiazolidine-2,4-dione potassium salt |
| 02/08/2006 | EP1623728A1 Nitric oxide-releasing metallic medical devices |
| 02/08/2006 | EP1623710A1 Receptor antagonist |
| 02/08/2006 | EP1622639A2 Intravenous injection of plasminogen non-neurotoxic activators for treating cerebral stroke |
| 02/08/2006 | EP1622621A2 Use of dipyridamole or mopidamole for treatment and prevention of thrombo-embolic diseases and disorders caused by excessive formation of thrombin and/or by elevated expression of thrombin receptors |
| 02/08/2006 | EP1423082A4 Plasma protein matrices and methods for their preparation |
| 02/08/2006 | EP1131292B1 Acyclic and cyclic guanidine- and acetamidine derivatives, their preparation and their use as pesticides, esp. as parasiticides |
| 02/08/2006 | EP0932600B1 Sulfonamide substituted aspartic acid interleukin-1beta converting enzyme inhibitors |
| 02/08/2006 | CN1732182A Peptides and medicinal compositions containing the same |
| 02/08/2006 | CN1731988A Sustained release pharmaceutical composition |
| 02/08/2006 | CN1730488A Peptides for promoting platelet growth, accumulation and suppressing hypertension and its uses |
| 02/08/2006 | CN1730098A Composition containing active prourokinase, freeze-drying process and freeze-dried preparation thereof |
| 02/08/2006 | CN1730075A Preparation method of blood enriching tablet |
| 02/08/2006 | CN1730067A Dispersible tablet for treating blood syndrome, its preparation method and purposes |
| 02/08/2006 | CN1730037A Process for preparing thrombus eliminating dripping pills |
| 02/08/2006 | CN1730012A Chinese medicinal formulation containing scutellarin and its preparing process |
| 02/08/2006 | CN1730004A Blood caring soft capsule and preparation process thereof |
| 02/08/2006 | CN1240719C New-type bifunctional hirudin and its preparation method and application |
| 02/08/2006 | CN1240436C Synergistic action of ossification growth peptide and granule cell colony stimulating factor in hematopoiesis |
| 02/08/2006 | CN1240415C Tablets against allergic purpura |
| 02/08/2006 | CN1240396C Haemostatic styptic for external use |
| 02/08/2006 | CN1240391C Daidzein drip pill and its preparation method |
| 02/07/2006 | US6995238 Cyclopeptide derivatives |
| 02/07/2006 | US6995184 Such as (7-chloro-2-methyl-1-(3-(methylsulphanyl)propyl)-1H-indol-3-yl)(2,3-dichloro-phenyl)methanone; cannabinoid receptors (cb2); G proteins coupled receptors |
| 02/07/2006 | US6995172 Lactam-containing compounds and derivatives thereof as factor Xa inhibitors |
| 02/07/2006 | US6995156 Platelet adenosine diphosphate receptor antagonists |
| 02/07/2006 | US6994863 Pharmaceutical and cosmetic carrier and composition for topical application |
| 02/07/2006 | US6994857 A Therapeutic protein (e.g., a polypeptide, antibody, or peptide, or fragments and variants) fused to albumin, is sufficient to prolong the shelf-lilfe of therapeutic protein |
| 02/07/2006 | CA2273479C 6-phenylpyridyl-2-amine derivatives useful as nos inhibitors |
| 02/02/2006 | WO2006011670A1 PYRROLO[2,3-c]PYRIDINE COMPOUND, PROCESS FOR PRODUCING THE SAME, AND USE |
| 02/02/2006 | US20060025590 Novel compounds |
| 02/02/2006 | US20060025570 Megakaryocyte stimulating factors |
| 02/02/2006 | US20060025464 Benzimidazole derivatives as therapeutic agents |
| 02/02/2006 | US20060025442 Acylated piperidine derivatives as melanocortin-4 receptor agonists |
| 02/02/2006 | US20060025432 N-[2-[(3-Chloro-2-fluorobenzyl)thio]-6-[(2-hydroxy-1-methylethyl)amino]-4-pyrimidinyl]- 4-morpholinesulfonamide; asthma, antiallergens; rhinitis, chronic obstructive pulmonary disease, inflammatory bowel disease, irritable bowel syndrome, osteoarthritis, osteoporosis, rheumatoid arthritis, psoriasis |
| 02/02/2006 | US20060025428 Bicyclic heteroaromatic compounds as kinase inhibitors |
| 02/02/2006 | US20060025423 2,3-Dichloro-N-(3-methoxy-5-methyl-2-pyrazinyl)-benzenesulphonamide; inflammatory diseases, such as asthma |
| 02/02/2006 | US20060025413 3-(arylamino)methylene-1,3-dihydro-2H-indol-2-ones as kinase inhibitors |
| 02/02/2006 | US20060025403 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same |
| 02/02/2006 | US20060025352 Glucopyranosyloxypyrazole derivatives and use thereof in medicines |
| 02/02/2006 | US20060024792 G-protein coupled receptors |
| 02/02/2006 | US20060024664 Characterizing purity and activity of polysaccharide preparations including glycosaminoglycans such as heparin |
| 02/02/2006 | US20060024349 Method for creating a separation of posterior cortical vitreous from the retina of the eye |
| 02/02/2006 | US20060024293 Antibody for use in the treatment and prevention of sepsis, infections, autoimmune and graft-versus-host diseases; biodegradable, biocompatible polymer and human antibody, or an antigen-binding portion thereof, that dissociates from human TNF alpha |
| 02/02/2006 | US20060024275 Methods for use of MPL ligands with primitive human stem cells |
| 02/02/2006 | CA2575283A1 Method for the preparation of crystal forms of torsemide in a pure state |
| 02/02/2006 | CA2574920A1 Pharmaceutical combinations containing an inhibitor of platelet aggregation and a fibrate |
| 02/02/2006 | CA2570634A1 1 (indole-6-carbonyl-d-phenylglycinyl) -4- (1-methylpiperidin-4-yl) piperazine d-tartrate |
| 02/01/2006 | EP1621537A1 Five-membered heterocyclic derivative |
| 02/01/2006 | EP1621207A2 Mixture of defibrotide and G-CSF, and its use for activating haematopoietic progenitors |
| 02/01/2006 | EP1621200A1 Pharmaceutical combinations containing an inhibitor of platelet aggregation and a fibrate |
| 02/01/2006 | EP1620107A1 Method of improved diuresis in individuals with impaired renal function |
| 02/01/2006 | EP1430144A4 METHODS OF USING 69039, A NOVEL HUMAN Na/Ca EXCHANGER FAMILY MEMBER |
| 02/01/2006 | EP1328266B1 Combination of fenofibrate and coenzyme q10 for the treatment of endothelial dysfunction |
| 02/01/2006 | EP1268502B1 O-aryl glucoside sglt2 inhibitors and method |
| 02/01/2006 | EP1194409B1 Pyrazolidinol compounds |
| 02/01/2006 | EP0859613B1 Use of flupirtin for the prevention and treatment of diseases which are associated with damage to the haemopoietic cell system |
| 02/01/2006 | CN1727354A Compound in category of trioside methyl salicylate, oside ester saccharide |
| 02/01/2006 | CN1727002A Compound bioogic component and pharmaceutical preparation possessing function for accelerating hemoglutination |
| 02/01/2006 | CN1726909A Butylbenzene phthalein self emulsifying releasing medicine system, preparation method and application |
| 02/01/2006 | CN1726884A Bracket for eluting medication |
| 02/01/2006 | CN1239485C Benzophenones as inhibitors of IL-1 beta and TNF-alpha |
| 02/01/2006 | CN1239478C 3,4-dibidro-1H-anphthalene derivatives used as high selectivity inhibitor of cyclooxygenase-2 |
| 02/01/2006 | CN1239173C Chinese medicine prepn for treating hemopathy |
| 01/31/2006 | US6992074 2-Ethyl and 2-ethylidene-19-nor-vitamin D compounds |
| 01/31/2006 | US6992070 Treating tissue with phosphodiesterase inhibitor compound and administering exogenous nucleic acid |
| 01/31/2006 | US6991817 Acid-modified arabinogalactan protein composition |
| 01/31/2006 | US6991624 Methods and compositions for use in perfusion applications |
| 01/31/2006 | CA2390104C Method for transfer of molecular substances with prokaryotic nucleic acid-binding proteins |
| 01/26/2006 | WO2006009092A1 Method of effectively using medicine and method concerning prevention of side effect |
| 01/26/2006 | WO2005121102A3 Factor viia inhibitor |